Beth Allen Sanders

Beth Allen Sanders currently serves as the Senior Director of Strategic Accounts at Harrow Pharmaceuticals since October 2024. Prior to this role, Beth held various positions at Apellis Pharmaceuticals, including Associate Director of Strategic Accounts and Thought Leader Liaison. Additionally, Beth has been with Regeneron Pharmaceuticals since July 2011, where roles included Medical Specialist in the Cleveland Ophthalmology Division and Associate Director of Thought Leader Liaison. With previous experience at GTx Inc, Celgene, MGI Pharma, Immunex, Genta, and Berlex, Beth has extensive expertise in oncology sales and clinical sales for therapeutics. Beth holds a Bachelor of Science in Nursing from the University of Delaware, attained between 1988 and 1993.